Lower MeDiC score is associated with non-referral to multidisciplinary team meeting discussion in bladder cancer patients: a nationwide and population-based study

Median total MeDiC score was lower in individuals not being discussed at an MDTM (7.0 Inter Quartile Range [IQR] 6.0-9.0) compared to those who were (8.0 IQR 6.0-10.0). Adjusted odds ratio for not being discussed at an MDTM was 2.1 (95% confidence interval [CI] 1.8-2.4) for a MeDiC score in the lower quartile, as compared to the highest quartile, with higher estimates when performing stratified analyses in later calendar years and in specific healthcare regions. Our data indicate that the MeDiC score is applicable in bladder cancer patients, and we identified an association between lower MeDiC score and not being discussed at an MDTM.

Authors

Institutions

Publication Details

Journal
Acta Oncologica
Published
2025-05-05
DOI
https://doi.org/10.2340/1651-226x.2025.42756
Primary Topic
Genetic factors in colorectal cancer
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Lower MeDiC score is associated with non-referral to multidisciplinary team meeting discussion in bladder cancer patients: a nationwide and population-based study

Viveka Ströck, Truls Gårdmark, Fredrik Liedberg, Oskar Hagberg et al.
Acta Oncologica
Genetic factors in colorectal cancer
article

Lower MeDiC score is associated with non-referral to multidisciplinary team meeting discussion in bladder cancer patients: a nationwide and population-based study

Viveka Ströck, Truls Gårdmark, Fredrik Liedberg, Oskar Hagberg, Tomas Jerlström, Staffan Jahnson, Lars Holmberg, Firas Aljabery, Jessica Wihl, Christel Häggström, Karin Söderkvist, Anders Ullén, Abolfazl Hosseini
article en

Abstract

Median total MeDiC score was lower in individuals not being discussed at an MDTM (7.0 Inter Quartile Range [IQR] 6.0-9.0) compared to those who were (8.0 IQR 6.0-10.0). Adjusted odds ratio for not being discussed at an MDTM was 2.1 (95% confidence interval [CI] 1.8-2.4) for a MeDiC score in the lower quartile, as compared to the highest quartile, with higher estimates when performing stratified analyses in later calendar years and in specific healthcare regions. Our data indicate that the MeDiC score is applicable in bladder cancer patients, and we identified an association between lower MeDiC score and not being discussed at an MDTM.

Acta OncologicaVol. 64
Linköping University (SE), Uppsala University (SE), Karolinska University Hospital (SE), Lund University (SE), Örebro University (SE), Sahlgrenska University Hospital (SE), Karolinska Institutet (SE), Skåne University Hospital (SE), University of Gothenburg (SE), Umeå University (SE)
Cancerfonden, Fondation pour la Recherche Médicale, Vetenskapsrådet, Skånes universitetssjukhus
Openalex Percentile: Top 86%
Genetic factors in colorectal cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.